Merck (NYSE:MRK) received European Union approval for KEYTRUDA in combination regimens for adults with platinum-resistant ...

Merck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.

The lack of a dose-response effect could be due to the high number of dropouts in the higher-dose Winrevair arm and the relatively small study population, a discussant for Merck explained.

Merck headquarters in Rahway, NJ. RAWAY, N.J. – Merck today announced fourth quarter earnings and revenue that beat Wall Street estimates. However, Merck, the giant pharmaceutical company with ...

RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based pharmaceutical giant has completed its $9.2 billion acquisition of Cidara ...

Dow Jones drug giant Merck, along with Costco Wholesale, are among the best stocks to watch in the ongoing stock market ...

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The pharmaceutical giant is finding ways to navigate despite headwinds. This has helped the shares outperform the market over the past year. Income investors should be pleased with Merck's dividend ...

Merck's business is growing, but the stock's gains have been modest this year. The drug manufacturer remains heavily reliant on Keytruda, which accounts for nearly half of its revenue. Merck has been ...

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Merck (NYSE: MRK), known ...